Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Phase IIIb Trial

被引：0
|
作者：
Lancaster, L. H. [1 ]
Conoscenti, C. S. [2 ]
Ilowite, J. [3 ]
Trampisch, M. [4 ]
Mogulkoc, N. [5 ]
Homik, L. [6 ]
Kaye, M. [7 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[3] NYU Winthrop, Div Pulm & Crit Care, Mineola, NY USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Ege Univ, Sch Med, Izmir, Turkey
[6] Winnipeg Clin, Winnipeg, MB, Canada
[7] Minnesota Lung Ctr Ltd, Minneapolis, MN USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4266
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Gas Exchange During Sleep and Exercise in Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Lee, R.
    Kelly, E.
    Lawless, G.
    Keane, M. P.
    McNicholas, W. T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S415 - S416
  • [32] SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): LONG-TERM GLOBAL PHARMACOVIGILANCE DATA
    Lasky, Joseph
    Criner, Gerard
    Lazarus, Howard
    Kohlbrenner, Veronika
    Bender, Shaun
    Richeldi, Luca
    CHEST, 2019, 156 (04) : 1011A - 1012A
  • [33] Relationship between nintedanib exposure, clinical efficacy and adverse events in patients with idiopathic pulmonary fibrosis (IPF)
    Schmid, U.
    Weber, B.
    Dallinger, C.
    Richeldi, L.
    Hallmann, C.
    Raghu, G.
    Freiwald, M.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S42 - S42
  • [34] Characteristics of patients with idiopathic pulmonary fibrosis (IPF) initiating nintedanib or pirfenidone treatment compared with untreated patients in the US
    Near, Aimee M.
    Burudpakdee, Chakkarin
    Wallace, Laura
    Hartmann, Nadine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 163 - 164
  • [35] Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis ( PPF)
    Wuyts, Wim A.
    Maher, Toby M.
    Wijsenbeek, Marlies
    Koschel, Dirk
    Martinez, Fernando J.
    Stansen, Wibke
    Stowasser, Susanne
    Richeldi, Luca
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [36] Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF)
    Koschel, D.
    Wuyts, W.
    Maher, T.
    Wijsenbeek, M.
    Martinez, F.
    Stansen, W.
    Stowasser, S.
    Richeldi, L.
    PNEUMOLOGIE, 2024, 78 : S81 - S82
  • [37] POOLED ANALYSIS OF MORTALITY DATA FROM THE TOMORROW AND INPULSIS TRIALS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Corte, T.
    Richeldi, L.
    Kirsten, A.
    Roman, J.
    Le Maulf, F.
    Hallmann, C.
    Stowasser, S.
    Lasky, J.
    RESPIROLOGY, 2015, 20 : 87 - 87
  • [38] Prescription Of Pirfenidone And Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf): An Academic Center Experience
    Strock, S.
    Nouraie, S. M.
    Huttenhower, D.
    Chen, X.
    Lawson, K.
    Priore, M. Melissa
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [39] Gene Expression Profiling in Patients with Idiopathic Pulmonary Fibrosis (IPF) in the INMARK Trial
    Selman, M.
    Jenkins, R. G.
    White, E. S.
    Cottin, V.
    Nishioka, Y.
    Noth, I.
    Prasse, A.
    Song, J.
    Strobel, B.
    Leparc, G.
    Ittrich, C.
    Diefenbach, C.
    Rohr, K.
    Stowasser, S.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [40] Implications Of Pulmonary Physiology And Exercise Testing Results In Idiopathic Pulmonary Fibrosis (ipf) In A Real World Cohort
    Sharp, C.
    Dixon, G.
    Edwards, A.
    Adamali, H.
    Millar, A. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345